New Products ' Services

November 1, 2004

FDA approves new 12-month LHRH implant for prostate Ca

The product uses Valera's Hydron Implant technology, which allows for the formulation of highly compact, lightweight, flexible, and retrievable subcutaneous implants that can be administered in a physician's office, according to the company.

For more information, visit http://www.ValeraPharma.com/.

The system's three-dimensional vision greatly enhances a surgeon's ability to gauge depth perception and operate with precision, Viking says. The head-mounted display allows each member of the surgical team a view of the surgery through their natural field of vision. Contact with the patient never has to stop, since the surgeon does not need to look at a separate monitor.

The EndoSite 3Di Digital Vision System features the Infomatix information platform, which makes voice-activated, picture-in-picture presentation of images possible, including clinical information from a patient's record.

For more information,visit http://www.vikingsystems.com/.

Treatment for trichomoniasis effective, well-tolerated

Arlington Heights, IL-The FDA has approved Presutti Laboratories' tinidazole (Tindamax) for the treatment of trichomoniasis in both men and women.

In published clinical studies, treatment with the drug has been found effective in 92% to 100% of patients with trichomoniasis, including cases where metronidazole, the only previously available therapy, had failed.

Tinidazole can be prescribed with a 1-day dosage regimen, and in clinical trials has been associated with nearly half the incidence of gastrointestinal side effects compared with metronidazole.

Approved dosing for trichomoniasis is a single 2-gram dose.

Simultaneous treatment of both sexual partners is essential to prevent reinfection, according to the company.

For more information, contact (847) 359-7800; presind@aol.com
.

Accessories now available for ultrasound system Kalona, IA-CIVCO Medical Instruments has introduced a number of accessories compatible with the Philips iU22 ultrasound system, including several needle guidance systems.

The Ultra-Pro II and Multi-Pro 2000 needle guidance systems use a two-part system in which a disposable needle guide is affixed to a non-sterile, reusable bracket. Once attached to the transducer, the guide provides secure and accurate placement of the needle in ultrasound-guided biopsy procedures. The Ultra-Pro II features a locking mechanism allowing the guide to be released quickly and easily while maintaining secure needle placement.

The Infiniti needle guide offers a multi-angled capability for shallow ultrasound-guided biopsy and instrument placement procedures. It positions the instrument in the scan plane and uses a two-part needle guidance system in which the needle guide attaches to the reusable brackets.

Endocavity needle guidance systems are also compatible with the new ultrasound system including 3D9-3v, C8-4v, and C9-5ec.

For more information, visit http://www.civco.com/.